{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:26:08Z","timestamp":1792686368601,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-025-02407-0","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T16:52:08Z","timestamp":1766508728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Deacetylasperulosidic Acid Methyl Ester Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis by Suppressing Inflammation and Modulating Gut Microbiota"],"prefix":"10.1007","volume":"49","author":[{"given":"Li","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"issue":"3","key":"2407_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri3623","volume":"14","author":"A Pellicoro","year":"2014","unstructured":"Pellicoro, A., P. Ramachandran, J. P. Iredale, and J. A. Fallowfield. 2014. Liver fibrosis and repair: Immune regulation of wound healing in a solid organ. Nature Reviews Immunology 14 (3): 181\u2013194.","journal-title":"Nature Reviews Immunology"},{"issue":"1","key":"2407_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5152\/tjg.2018.17330","volume":"29","author":"MM Ayd\u0131n","year":"2018","unstructured":"Ayd\u0131n, M. M., and K. C. Ak\u00e7al\u0131. 2018. Liver fibrosis. Turkish Journal of Gastroenterology 29 (1): 14\u201321.","journal-title":"Turkish Journal of Gastroenterology"},{"issue":"7","key":"2407_CR3","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","volume":"36","author":"P Horn","year":"2024","unstructured":"Horn, P., and F. Tacke. 2024. Metabolic reprogramming in liver fibrosis. Cell Metabolism 36 (7): 1439\u20131455.","journal-title":"Cell Metabolism"},{"issue":"1","key":"2407_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1146\/annurev-pharmtox-020524-012013","volume":"65","author":"H Gilgenkrantz","year":"2025","unstructured":"Gilgenkrantz, H., R. A. Sayegh, and S. Lotersztajn. 2025. Immunoregulation of liver fibrosis: New opportunities for antifibrotic therapy. Annual Review of Pharmacology and Toxicology 65 (1): 281\u2013299.","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"9","key":"2407_CR5","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1136\/gutjnl-2023-331785","volume":"73","author":"K Breitkopf-Heinlein","year":"2024","unstructured":"Breitkopf-Heinlein, K., and M. L. Martinez-Chantar. 2024. Targeting hepatic stellate cells to combat liver fibrosis: Where do we stand? Gut 73 (9): 1411\u20131413.","journal-title":"Gut"},{"issue":"5","key":"2407_CR6","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1159\/000445269","volume":"34","author":"Y Koyama","year":"2016","unstructured":"Koyama, Y., J. Xu, X. Liu, and D. A. Brenner. 2016. New developments on the treatment of liver fibrosis. Digestive Diseases 34 (5): 589\u2013596.","journal-title":"Digestive Diseases"},{"issue":"9","key":"2407_CR7","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s40265-019-01126-9","volume":"79","author":"P Manka","year":"2019","unstructured":"Manka, P., A. Zeller, and W. K. Syn. 2019. Fibrosis in chronic liver disease: An update on diagnostic and treatment modalities. Drugs 79 (9): 903\u2013927.","journal-title":"Drugs"},{"issue":"10","key":"2407_CR8","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","volume":"20","author":"L Hammerich","year":"2023","unstructured":"Hammerich, L., and F. Tacke. 2023. Hepatic inflammatory responses in liver fibrosis. Nature Reviews Gastroenterology and Hepatology 20 (10): 633\u2013646.","journal-title":"Nature Reviews Gastroenterology and Hepatology"},{"key":"2407_CR9","doi-asserted-by":"publisher","first-page":"1497095","DOI":"10.3389\/fimmu.2025.1497095","volume":"16","author":"Z Zhang","year":"2025","unstructured":"Zhang, Z., J. Wang, H. Li, Q. Niu, Y. Tao, X. Zhao, Z. Zeng, and H. Dong. 2025. The role of the interleukin family in liver fibrosis. Frontiers in Immunology 16:1497095.","journal-title":"Frontiers in Immunology"},{"issue":"5","key":"2407_CR10","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","volume":"81","author":"V Taru","year":"2024","unstructured":"Taru, V., G. Szabo, W. Mehal, and T. Reiberger. 2024. Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation. Journal of Hepatology 81 (5): 895\u2013910.","journal-title":"Journal of Hepatology"},{"issue":"1","key":"2407_CR11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/HEP.0000000000000479","volume":"81","author":"H Gilgenkrantz","year":"2025","unstructured":"Gilgenkrantz, H., V. Paradis, and S. Lotersztajn. 2025. Cell metabolism-based therapy for liver fibrosis, repair, and hepatocellular carcinoma. Hepatology 81 (1): 269\u2013287.","journal-title":"Hepatology"},{"issue":"11","key":"2407_CR12","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","volume":"21","author":"CL Hsu","year":"2023","unstructured":"Hsu, C. L., and B. Schnabl. 2023. The gut-liver axis and gut microbiota in health and liver disease. Nature Reviews Microbiology 21 (11): 719\u2013733.","journal-title":"Nature Reviews Microbiology"},{"issue":"7681","key":"2407_CR13","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1038\/d41586-017-06924-3","volume":"551","author":"A Scott","year":"2017","unstructured":"Scott, A. 2017. Gut-liver axis: Menace in the microbiota. Nature 551 (7681): S94-s95.","journal-title":"Nature"},{"key":"2407_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216502","author":"R Maslennikov","year":"2023","unstructured":"Maslennikov, R., E. Poluektova, O. Zolnikova, A. Sedova, A. Kurbatova, Y. Shulpekova, N. Dzhakhaya, S. Kardasheva, M. Nadinskaia, E. Bueverova, et al. 2023. Gut microbiota and bacterial translocation in the pathogenesis of liver fibrosis. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms242216502.","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"2407_CR15","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos, A., A. de Gottardi, and M. Rescigno. 2020. The gut-liver axis in liver disease: Pathophysiological basis for therapy. Journal Of Hepatology 72 (3): 558\u2013577.","journal-title":"Journal Of Hepatology"},{"issue":"4","key":"2407_CR16","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1002\/hep.27819","volume":"62","author":"JS Bajaj","year":"2015","unstructured":"Bajaj, J. S., N. S. Betrapally, P. B. Hylemon, D. M. Heuman, K. Daita, M. B. White, A. Unser, L. R. Thacker, A. J. Sanyal, D. J. Kang, et al. 2015. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy. Hepatology 62 (4): 1260\u20131271.","journal-title":"Hepatology"},{"issue":"8","key":"2407_CR17","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1111\/jgh.15487","volume":"36","author":"M Iwaki","year":"2021","unstructured":"Iwaki, M., T. Kessoku, A. Ozaki, Y. Kasai, T. Kobayashi, A. Nogami, Y. Honda, Y. Ogawa, K. Imajo, M. Yoneda, et al. 2021. Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 36 (8): 2275\u20132284.","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"11","key":"2407_CR18","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.tips.2018.09.002","volume":"39","author":"DQ Chen","year":"2018","unstructured":"Chen, D. Q., Y. L. Feng, G. Cao, and Y. Y. Zhao. 2018. Natural products as a source for antifibrosis therapy. Trends in Pharmacological Sciences 39 (11): 937\u2013952.","journal-title":"Trends in Pharmacological Sciences"},{"issue":"31","key":"2407_CR19","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.2174\/0109298673288458240203064112","volume":"31","author":"T Wang","year":"2024","unstructured":"Wang, T., Z. Lu, G. F. Sun, K. Y. He, Z. P. Chen, X. H. Qu, and X. J. Han. 2024. Natural products in liver fibrosis management: A five-year review. Current Medicinal Chemistry 31 (31): 5061\u20135082.","journal-title":"Current Medicinal Chemistry"},{"key":"2407_CR20","doi-asserted-by":"publisher","first-page":"1508060","DOI":"10.3389\/fphar.2024.1508060","volume":"15","author":"C Wang","year":"2024","unstructured":"Wang, C., X. Feng, W. Li, L. Chen, X. Wang, Y. Lan, R. Tang, T. Jiang, L. Zheng, and G. Liu. 2024. Apigenin as an emerging hepatoprotective agent: Current status and future perspectives. Frontiers in Pharmacology 15:1508060.","journal-title":"Frontiers in Pharmacology"},{"key":"2407_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115410","volume":"166","author":"C Wang","year":"2023","unstructured":"Wang, C., R. Wu, S. Zhang, L. Gong, K. Fu, C. Yao, C. Peng, and Y. Li. 2023. A comprehensive review on pharmacological, toxicity, and pharmacokinetic properties of phillygenin: Current landscape and future perspectives. Biomedicine & Pharmacotherapy 166 : 115410.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"2407_CR22","doi-asserted-by":"publisher","first-page":"1574154","DOI":"10.3389\/fphar.2025.1574154","volume":"16","author":"C Chen","year":"2025","unstructured":"Chen, C., X. Bu, L. Deng, J. Xia, X. Wang, L. Chen, W. Li, J. Huang, Q. Chen, and C. Wang. 2025. Astragaloside IV as a promising therapeutic agent for liver diseases: Current landscape and future perspectives. Frontiers in Pharmacology 16:1574154.","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"2407_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1248\/bpb.19.160","volume":"19","author":"T Miura","year":"1996","unstructured":"Miura, T., Y. Nishiyama, M. Ichimaru, M. Moriyasu, and A. Kato. 1996. Hypoglycemic activity and structure-activity relationship of iridoidal glycosides. Biological & Pharmaceutical Bulletin 19 (1): 160\u2013161.","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"2407_CR24","doi-asserted-by":"publisher","first-page":"116641","DOI":"10.1016\/j.jep.2023.116641","volume":"315","author":"S Paramasivam","year":"2023","unstructured":"Paramasivam, S., and S. S. Perumal. 2023. Methanolic extract of O.umbellata L. exhibits anti-osteoporotic effect via promoting osteoblast proliferation in MG-63 cells and inhibiting osteoclastogenesis in RANKL-stimulated RAW 264.7 cells. Journal of Ethnopharmacology 315:116641.","journal-title":"Journal of Ethnopharmacology"},{"key":"2407_CR25","doi-asserted-by":"publisher","first-page":"154517","DOI":"10.1016\/j.phymed.2022.154517","volume":"108","author":"X Xue","year":"2023","unstructured":"Xue, X., X. Zhao, J. Wang, C. Wang, C. Ma, Y. Zhang, Y. Li, and C. Peng. 2023. Carthami flos extract against carbon tetrachloride-induced liver fibrosis via alleviating angiogenesis in mice. Phytomedicine 108:154517.","journal-title":"Phytomedicine"},{"issue":"4","key":"2407_CR26","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s10753-023-01826-1","volume":"46","author":"C Wang","year":"2023","unstructured":"Wang, C., Y. Liu, L. Gong, X. Xue, K. Fu, C. Ma, and Y. Li. 2023. Phillygenin ameliorates carbon tetrachloride-induced liver fibrosis: Suppression of inflammation and Wnt\/\u03b2-catenin signaling pathway. Inflammation 46 (4): 1543\u20131560.","journal-title":"Inflammation"},{"issue":"3","key":"2407_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva, T., and D. Brenner. 2021. Molecular and cellular mechanisms of liver fibrosis and its regression. Nature Reviews Gastroenterology & Hepatology 18 (3): 151\u2013166.","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"2407_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","volume":"65","author":"M Parola","year":"2019","unstructured":"Parola, M., and M. Pinzani. 2019. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. Molecular Aspects of Medicine 65:37\u201355.","journal-title":"Molecular Aspects of Medicine"},{"issue":"1 Suppl","key":"2407_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/0023677215571192","volume":"49","author":"D Scholten","year":"2015","unstructured":"Scholten, D., J. Trebicka, C. Liedtke, and R. Weiskirchen. 2015. The carbon tetrachloride model in mice. Laboratory Animals 49 (1 Suppl): 4\u201311.","journal-title":"Laboratory Animals"},{"issue":"2","key":"2407_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1515\/reveh-2020-0048","volume":"36","author":"V Unsal","year":"2021","unstructured":"Unsal, V., M. Cicek, and \u0130 Sabancilar. 2021. Toxicity of carbon tetrachloride, free radicals and role of antioxidants. Reviews on Environmental Health 36 (2): 279\u2013295.","journal-title":"Reviews on Environmental Health"},{"issue":"6","key":"2407_CR31","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1080\/10937404.2023.2220147","volume":"26","author":"SM Cohen","year":"2023","unstructured":"Cohen, S. M., C. Bevan, B. Gollapudi, and J. E. Klaunig. 2023. Evaluation of the carcinogenicity of carbon tetrachloride. Journal of Toxicology and Environmental Health, Part B: Critical Reviews 26 (6): 342\u2013370.","journal-title":"Journal of Toxicology and Environmental Health, Part B: Critical Reviews"},{"key":"2407_CR32","doi-asserted-by":"publisher","first-page":"115478","DOI":"10.1016\/j.jep.2022.115478","volume":"296","author":"C Wang","year":"2022","unstructured":"Wang, C., C. Ma, K. Fu, Y. Liu, L. Gong, C. Peng, and Y. Li. 2022. Hepatoprotective effect of phillygenin on carbon tetrachloride-induced liver fibrosis and its effects on short chain fatty acid and bile acid metabolism. Journal of Ethnopharmacology 296:115478.","journal-title":"Journal of Ethnopharmacology"},{"issue":"8","key":"2407_CR33","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1113\/JP281061","volume":"600","author":"DR Kamm","year":"2022","unstructured":"Kamm, D. R., and K. S. McCommis. 2022. Hepatic stellate cells in physiology and pathology. Journal of Physiology 600 (8): 1825\u20131837.","journal-title":"Journal of Physiology"},{"key":"2407_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147873","author":"H Akk\u0131z","year":"2024","unstructured":"Akk\u0131z, H., R. K. Gieseler, and A. Canbay. 2024. Liver fibrosis: From basic science towards clinical progress, focusing on the central role of hepatic stellate cells. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms25147873.","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"2407_CR35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MOG.0b013e3283279668","volume":"25","author":"J Jiao","year":"2009","unstructured":"Jiao, J., S. L. Friedman, and C. Aloman. 2009. Hepatic fibrosis. Current Opinion in Gastroenterology 25 (3): 223\u2013229.","journal-title":"Current Opinion in Gastroenterology"},{"issue":"2","key":"2407_CR36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","volume":"13","author":"F Heymann","year":"2016","unstructured":"Heymann, F., and F. Tacke. 2016. Immunology in the liver\u2013From homeostasis to disease. Nature Reviews Gastroenterology and Hepatology 13 (2): 88\u2013110.","journal-title":"Nature Reviews Gastroenterology and Hepatology"},{"issue":"18","key":"2407_CR37","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.3390\/cells13181590","volume":"13","author":"P Kumar","year":"2024","unstructured":"Kumar, P., E. A. Schroder, M. V. S. Rajaram, and E. N. Harris. 2024. Ganesan LP: the battle of LPS clearance in host defense vs. inflammatory signaling. Cells 13 (18): 1590.","journal-title":"Cells"},{"key":"2407_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020395","author":"I Milosevic","year":"2019","unstructured":"Milosevic, I., A. Vujovic, A. Barac, M. Djelic, M. Korac, A. Radovanovic Spurnic, I. Gmizic, O. Stevanovic, V. Djordjevic, N. Lekic, et al. 2019. Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: A review of the literature. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms20020395.","journal-title":"International Journal of Molecular Sciences"},{"key":"2407_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/nu11071613","author":"RD Hills Jr.","year":"2019","unstructured":"Hills, R. D., Jr., B. A. Pontefract, H. R. Mishcon, C. A. Black, S. C. Sutton, and C. R. Theberge. 2019. Gut microbiome: Profound implications for diet and disease. Nutrients. https:\/\/doi.org\/10.3390\/nu11071613.","journal-title":"Nutrients"},{"key":"2407_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119571","volume":"345","author":"S Gao","year":"2025","unstructured":"Gao, S., X. Wang, Q. Xu, R. Li, L. Yao, A. Zhang, Q. Zhou, Z. Xiao, S. Li, X. Meng, et al. 2025. Total Sanghuangporus vaninii extract inhibits hepatocyte ferroptosis and intestinal microbiota disturbance to attenuate liver fibrosis in mice. Journal of Ethnopharmacology 345 : 119571.","journal-title":"Journal of Ethnopharmacology"},{"key":"2407_CR41","doi-asserted-by":"publisher","first-page":"111305","DOI":"10.1016\/j.cbi.2024.111305","volume":"405","author":"Q Liu","year":"2025","unstructured":"Liu, Q., L. X. Liu, B. M. Li, W. Zhang, Y. Zhang, P. Chen, C. K. Huang, Y. Nie, and X. Zhu. 2025. Exploring the mechanism of ursolic acid in preventing liver fibrosis and improving intestinal microbiota based on NOX2\/NLRP3 inflammasome signaling pathway. Chemico-Biological Interactions 405:111305.","journal-title":"Chemico-Biological Interactions"},{"key":"2407_CR42","doi-asserted-by":"publisher","first-page":"102819","DOI":"10.1016\/j.anaerobe.2024.102819","volume":"85","author":"JH Shin","year":"2024","unstructured":"Shin, J. H., G. Tillotson, T. N. MacKenzie, C. A. Warren, H. M. Wexler, and E. J. C. Goldstein. 2024. Bacteroides and related species: The keystone taxa of the human gut microbiota. Anaerobe 85:102819.","journal-title":"Anaerobe"},{"issue":"3","key":"2407_CR43","doi-asserted-by":"publisher","first-page":"111087","DOI":"10.1016\/j.celrep.2022.111087","volume":"40","author":"S Tomioka","year":"2022","unstructured":"Tomioka, S., N. Seki, Y. Sugiura, M. Akiyama, J. Uchiyama, G. Yamaguchi, K. Yakabe, R. Ejima, K. Hattori, T. Kimizuka, et al. 2022. Cooperative action of gut-microbiota-accessible carbohydrates improves host metabolic function. Cell Reports 40 (3): 111087.","journal-title":"Cell Reports"},{"key":"2407_CR44","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.trsl.2020.07.008","volume":"227","author":"E Somm","year":"2021","unstructured":"Somm, E., S. A. Montandon, U. Loizides-Mangold, N. Ga\u00efa, V. Lazarevic, C. De Vito, E. Perroud, M. L. Bochaton-Piallat, C. Dibner, J. Schrenzel, et al. 2021. The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet. Translational Research 227:75\u201388.","journal-title":"Translational Research"},{"issue":"14","key":"2407_CR45","doi-asserted-by":"publisher","first-page":"e2100067","DOI":"10.1002\/mnfr.202100067","volume":"65","author":"F Xiong","year":"2021","unstructured":"Xiong, F., Z. Zheng, L. Xiao, C. Su, J. Chen, X. Gu, J. Tang, Y. Zhao, H. Luo, and L. Zha. 2021. Soyasaponin A(2) alleviates steatohepatitis possibly through regulating bile acids and gut microbiota in the methionine and choline-deficient (MCD) diet-induced nonalcoholic steatohepatitis (NASH) mice. Molecular Nutrition & Food Research 65 (14): e2100067.","journal-title":"Molecular Nutrition & Food Research"},{"issue":"1","key":"2407_CR46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41387-019-0097-6","volume":"9","author":"YF Bai","year":"2019","unstructured":"Bai, Y. F., S. W. Wang, X. X. Wang, Y. Y. Weng, X. Y. Fan, H. Sheng, X. T. Zhu, L. J. Lou, and F. Zhang. 2019. The flavonoid-rich Quzhou Fructus Aurantii extract modulates gut microbiota and prevents obesity in high-fat diet-fed mice. Nutrition & Diabetes 9 (1): 30.","journal-title":"Nutrition & Diabetes"},{"issue":"1","key":"2407_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41366-020-00712-2","volume":"45","author":"X Qiu","year":"2021","unstructured":"Qiu, X., M. G. Macchietto, X. Liu, Y. Lu, Y. Ma, H. Guo, M. Saqui-Salces, D. A. Bernlohr, C. Chen, S. Shen, et al. 2021. Identification of gut microbiota and microbial metabolites regulated by an antimicrobial peptide lipocalin 2 in high fat diet-induced obesity. International Journal of Obesity (London) 45 (1): 143\u2013154.","journal-title":"International Journal of Obesity (London)"},{"issue":"1","key":"2407_CR48","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41538-024-00334-2","volume":"8","author":"YY Xi","year":"2024","unstructured":"Xi, Y. Y., C. Chen, J. J. Zheng, B. Jiang, X. Y. Dong, S. Y. Lou, J. G. Luo, X. H. Zhang, Z. Y. Zhou, Q. J. Luo, et al. 2024. Ampelopsis grossedentata tea alleviating liver fibrosis in BDL-induced mice via gut microbiota and metabolite modulation. Npj Science of Food 8 (1): 93.","journal-title":"Npj Science of Food"},{"key":"2407_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/nu17030407","author":"X Cai","year":"2025","unstructured":"Cai, X., J. Huang, T. Yu, X. Guan, M. Sun, D. Zhao, Y. Zheng, and Q. Wang. 2025. Lactiplantibacillus plantarum BXM2 treatment alleviates disorders induced by a high-fat diet in mice by improving intestinal health and modulating the gut microbiota. Nutrients. https:\/\/doi.org\/10.3390\/nu17030407.","journal-title":"Nutrients"},{"issue":"7","key":"2407_CR50","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41575-023-00771-6","volume":"20","author":"O Pabst","year":"2023","unstructured":"Pabst, O., M. W. Hornef, F. G. Schaap, V. Cerovic, T. Clavel, and T. Bruns. 2023. Gut-liver axis: Barriers and functional circuits. Nature Reviews Gastroenterology and Hepatology 20 (7): 447\u2013461.","journal-title":"Nature Reviews Gastroenterology and Hepatology"},{"key":"2407_CR51","doi-asserted-by":"publisher","first-page":"756924","DOI":"10.3389\/fphar.2021.756924","volume":"12","author":"C Wang","year":"2021","unstructured":"Wang, C., C. Ma, K. Fu, L. H. Gong, Y. F. Zhang, H. L. Zhou, and Y. X. Li. 2021. Phillygenin attenuates carbon tetrachloride-induced liver fibrosis via modulating inflammation and gut microbiota. Frontiers in Pharmacology 12:756924.","journal-title":"Frontiers in Pharmacology"},{"key":"2407_CR52","doi-asserted-by":"publisher","first-page":"113185","DOI":"10.1016\/j.biopha.2022.113185","volume":"151","author":"K Fu","year":"2022","unstructured":"Fu, K., C. Ma, C. Wang, H. Zhou, L. Gong, Y. Zhang, and Y. Li. 2022. Forsythiaside a alleviated carbon tetrachloride-induced liver fibrosis by modulating gut microbiota composition to increase short-chain fatty acids and restoring bile acids metabolism disorder. Biomedicine & Pharmacotherapy 151:113185.","journal-title":"Biomedicine & Pharmacotherapy"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-025-02407-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02407-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02407-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:03:31Z","timestamp":1767665011000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-025-02407-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2407"],"URL":"https:\/\/doi.org\/10.1007\/s10753-025-02407-0","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were conducted in accordance with the Guidelines for the Care and Use of Laboratory Animals of Chengdu Medical College and approved by the Institutional Animal Care and Use Committee of Chengdu Medical College.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All authors have read the manuscript and authorized its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}